发明名称 OPHTHALMIC TREATMENTS
摘要 Aqueous compositions suitable for topical administration to the human or animal eye contain at least one water-soluble polymeric ophthalmic lubricant, such as hyaluronate, carbomer gel or hypromellose, together with a water-soluble analgesic. The analgesic may be an opiod, particularly an opioid having an affinity for 5-HT receptors, such as tramadol. Typical tramadol levels would be in the range of 0.5% to 1.0% w/v. The aqueous compositions may for example be used as artificial tears, and as general ophthalmic lubricants for treating conditions such as dry eye or blepharitis. Further compositions combine ophthalmologically- active agents, such as pharmaceuticals, with opioids, such as tramadol in particular. These compositions may be used to treat the eye while reducing pain or discomfort that would normally be produced by administering these particular pharmaceuticals to the eye, and increasing the efficacy of the pharmaceuticals. Compositions are also disclosed, containing opioids with 5-HT receptor activity, which are of general use in alleviating pain in and around the eye.
申请公布号 WO2012136969(A3) 申请公布日期 2013.01.03
申请号 WO2012GB00330 申请日期 2012.04.05
申请人 SHARMA, ANANT 发明人 SHARMA, ANANT
分类号 A61K31/135;A61K9/00;A61K9/08;A61K45/06 主分类号 A61K31/135
代理机构 代理人
主权项
地址